Treatment of severe postRYGB hyperinsulinemic hypoglycemia with pasireotide: a comparison with octreotide on insulin, glucagon, and GLP-1.
Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands. Electronic address: heideslot@hetnet.nl.
Loek J M
LJ
de Heide
Clinical Chemistry, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
Anke J
AJ
Laskewitz
Metabolic and Bariatric Surgery, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
Jan A
JA
Apers
D001786:Blood Glucose / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005765:Gastrointestinal Agents / Q000008:administration & dosage; D005934:Glucagon / Q000008:administration & dosage*; D052216:Glucagon-Like Peptide 1 / Q000008:administration & dosage*; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D006946:Hyperinsulinism / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D054795:Incretins / Q000008:administration & dosage; D007328:Insulin / Q000008:administration & dosage* / Q000097:blood; D008875:Middle Aged; D009767:Obesity, Morbid / Q000097:blood / Q000601:surgery*; D015282:Octreotide / Q000008:administration & dosage*; D012720:Severity of Illness Index
D001786:Blood Glucose; D005765:Gastrointestinal Agents; D007004:Hypoglycemic Agents; D054795:Incretins; D007328:Insulin; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; D015282:Octreotide
GLP-1; Glucagon; Hyperinsulinemic hypoglycemia; Octreotide; Pasireotide; Roux-en-Y gastric bypass